Healthcare -
Biotechnology - NASDAQ - US
$ 18.37
-0.541 %
$ 1.6 B
Market Cap
-4.06
P/E
TVTX - STOCK-BASED COMPENSATION
Stock-based Compensation TVTX - Travere Therapeutics, Inc.
44.2 M
LAST VALUE
22.33%
2 YEAR CAGR
17.48%
5 YEAR CAGR
41.00%
10 YEAR CAGR